Inhibikase Therapeutics I...

NASDAQ: IKT · Real-Time Price · USD
1.74
0.03 (1.75%)
At close: Aug 15, 2025, 3:59 PM
1.75
0.47%
After-hours: Aug 15, 2025, 04:10 PM EDT

Inhibikase Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.8 -0.36 -0.7 -1.81
PEG Ratio
0.04 0.02 0.06 -0.01
PS Ratio
n/a 26.00 102.12 8.63
PB Ratio
0.81 0.62 0.60 0.70
P/FCF Ratio
-4.02 -0.37 -0.72 -1.87
P/OCF Ratio
-4.02 -0.37 -0.73 -1.87
OCF/S Ratio
n/a -69.42 -140.56 -4.61
Debt / Equity Ratio
0.00 0.06 0.02 0.01
Quick Ratio
26.37 4.13 6.29 10.45
Current Ratio
26.37 4.13 6.59 10.47
Asset Turnover
n/a 0.02 0.00 0.07
Interest Coverage
n/a n/a -243.49 -741.16
Return on Equity
-0.29 -1.73 -0.85 -0.39
Return on Assets
-0.28 -1.31 -0.72 -0.35
Return on Invested Capital
-0.3 -1.73 -0.83 -0.38
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a -51.28 0.95 -2.66
Net Profit Margin
n/a -73.05 -145.05 -4.78
Pretax Profit Margin
n/a -73.05 -146.26 -4.77
Operating Profit Margin
n/a -77.12 -146.86 -4.76
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a -76.44 -146.81 -4.76